LIN Linde plc
Best-in-class gas oligopolist, but the price assumes perfection that a mid-single-digit grower struggles to justify.
The story
Linde is the world's largest industrial gas company and operates in a disciplined global oligopoly with Air Liquide and Air Products. Its moat comes from 15-20 year take-or-pay on-site contracts, local pipeline and distribution density, and pricing power that has expanded margins even while volumes were flat. It is a mature, defensive compounder; the extra growth comes from a roughly $7B+ contracted project backlog in electronics, clean hydrogen and decarbonization.
Growth is set above the flat 5-year CAGR, which was depressed by FX, divestitures and the Russia exit, because pricing plus the contracted backlog support about 5% growth. Target margin of 30% matches adjusted margins once the Praxair merger amortization rolls off. Marginal sales-to-capital is 1.0 rather than the historical 0.54, since the reported capital base is inflated by merger goodwill. The 12-year horizon reflects a durable oligopoly with long-dated contracts, and beta of 0.9 reflects defensive, contract-backed cash flows; the market price still implies more optimism than these drivers.
Value drivers
| Revenue growth (Y1) | 5.5% |
| Terminal growth | 4.0% |
| Forecast horizon | 12y |
| Target operating margin | 30.0% |
| Years to target margin | 5 |
| Sales-to-capital | 1.00 |
| Beta | 0.90 |
| Failure probability | 0.5% |
| Cost of capital (WACC) | 8.8% |
| Terminal WACC | 9.2% |
Valuation bridge
| PV of explicit FCFF | 62.54B |
| PV of terminal value | 69.05B |
| Equity value | 107.60B |
| ÷ shares → per share | $233.43 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 37.40B | 5.5% | 28.1% | 8.17B | 1.95B | 6.22B | 5.72B |
| 2 | 39.40B | 5.4% | 28.6% | 8.75B | 2.01B | 6.74B | 5.70B |
| 3 | 41.46B | 5.2% | 29.1% | 9.36B | 2.06B | 7.30B | 5.67B |
| 4 | 43.58B | 5.1% | 29.5% | 9.99B | 2.11B | 7.88B | 5.63B |
| 5 | 45.73B | 5.0% | 30.0% | 10.65B | 2.16B | 8.49B | 5.57B |
| 6 | 47.94B | 4.8% | 30.0% | 11.17B | 2.20B | 8.96B | 5.41B |
| 7 | 50.18B | 4.7% | 30.0% | 11.69B | 2.24B | 9.44B | 5.24B |
| 8 | 52.46B | 4.5% | 30.0% | 12.22B | 2.28B | 9.94B | 5.07B |
| 9 | 54.78B | 4.4% | 30.0% | 12.76B | 2.31B | 10.45B | 4.89B |
| 10 | 57.12B | 4.3% | 30.0% | 13.30B | 2.34B | 10.96B | 4.72B |
| 11 | 59.48B | 4.1% | 30.0% | 13.85B | 2.36B | 11.49B | 4.55B |
| 12 | 61.86B | 4.0% | 30.0% | 14.41B | 2.38B | 12.03B | 4.38B |
Key risks
- Industrial volume slowdown in Europe and China pressures base business
- Clean hydrogen and decarbonization projects deliver lower returns than expected or get cancelled as subsidies change
- Premium valuation multiple compresses if pricing power fades as inflation normalizes
Catalysts
- Backlog projects (electronics fabs, blue hydrogen, US Gulf Coast) start up and add contracted revenue
- Continued margin expansion and buybacks lift EPS toward 8-10% annual growth